Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    HCDr. Hetty Carraway

    Dr. Hetty Carraway

    Hematology & Oncology · Leukemia
    Cleveland Clinic
    hetty

    Research

    Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

    2025

    Via Blood

    Research

    Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference

    2025

    Via Clinical Lymphoma, Myeloma & Leukemia

    Research

    Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes

    2024

    Via The Lancet Haematology

    Research

    Clonal hematopoiesis in large granular lymphocytic leukemia

    2024

    Via Leukemia

    Research

    Complete remission of fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib

    2024

    Via Haematologica

    Research

    Toward a More Patient-Centered Drug Development Process in Clinical Trials for Patients With Myelodysplastic Syndromes/Neoplasms (MDS): Practical Considerations From the International Consortium for MDS (icMDS)

    2024

    Via HemaSphere

    Research

    Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients

    2024

    Via Current Treatment Options in Oncology

    Research

    Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence

    2024

    Via Blood

    Research

    Clinical and Molecular Characteristics of Extramedullary Acute Myeloid Leukemias

    2024

    Via Leukemia

    Research

    Non-canonical FLT3 Alterations Reveal Novel Germline FLT3 Variants Leading to Somatic Gene Rescue Mutations

    2024

    Via Blood Cancer Journal

    Research

    Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

    2024

    Via Modern Pathology

    Research

    Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome

    2023

    Via Blood Advances

    Research

    An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

    2023

    Via Blood Advances

    Research

    Validation of the Molecular International Prognostic Scoring System in Patients With Myelodysplastic Syndromes

    2023

    Via Blood

    Research

    Consensus Proposal for Revised International Working Group 2023 Response Criteria for Higher-Risk Myelodysplastic Syndromes

    2023

    Via Blood